Thanks in large part to producing hundreds of college-trained professionals, Houston’s life sciences industry ranks among the top U.S. markets for talent in 2024.

In a report published by commercial real estate services company CBRE, Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. From 2017 to 2022, Houston notched a growth rate of 32.4 percent in this category.

In 2022, the University of Houston led the higher education pack in the region, graduating 746 people with a bachelor’s degree or above in biological or biomedical sciences, according to the report.

“For years, our team has seen the positive effect that the increase in degreed life sciences professionals has had on the Houston life sciences sector,” Nelson Udstuen, senior vice president of CBRE’s healthcare and life sciences practice group in Houston, says in a news release. “This is the result of the rigorous investment and recruitment in place by several of our region’s finest academic institutions.”

Houston ranks within the top 15 across the report’s three subcategories: No. 4 in manufacturing talent, No. 12 in R&D, and No. 14 in medtech talent. Houston is one of 16 markets appearing within the top 25 for all three subsectors.

Manufacturing, Houston’s highest-rated life sciences talent subsector, includes drug manufacturing as well as cell and gene therapy. The report tallies 38,370 workers in the manufacturing segment, with more than two-thirds of them (37 percent) employed as inspectors, testers, sorters, samplers, and weighers.

The report also identifies 15,690 R&D specialists and 32,170 medtech professionals in the Houston life sciences market.

For the report, CBRE evaluated various criteria for the 100 largest U.S. for life sciences labor.